Oral contraceptive pills are associated with artifacts in ThinPrep Pap smears that mimic low-grade squamous intraepithelial lesions

Cancer

Volumn 99, Issue 2, 2003, Pages 75-82

  Morrison, Carl ^a   Prokorym, Patricia ^a   Piquero, Clara ^a   Wakely Jr , Paul E ^a   Nuovo, Gerard J ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Atypical squamous cells of undetermined significance (ASCUS); AutoCyte; Human papillomavirus; In situ hybridization; Oral contraceptive therapy; Premenopausal women; ThinPrep

Indexed keywords

GLYCOGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; ARTIFACT; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; COLPOSCOPY; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PAPANICOLAOU TEST; PERIODIC ACID SCHIFF STAIN; PREMENOPAUSE; PRIORITY JOURNAL; SQUAMOUS CELL; SQUAMOUS EPITHELIUM; UTERINE CERVIX DYSPLASIA; UTERUS BIOPSY; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; ARTIFACTS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONTRACEPTIVES, ORAL; DNA, VIRAL; FALSE POSITIVE REACTIONS; FEMALE; GLYCOGEN; HUMANS; IN SITU HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PREMENOPAUSE; RETROSPECTIVE STUDIES; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0038410010     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11056     Document Type: Article

References (30)

1. Monsonego J, Autillo-Touati A, Bergeron C, et al. Liquid-based cytology for primary cervical cancer screening: a multi-centre study. Br J Cancer. 2001;84:360-366.
2. Weintraub J, Morabia A. Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer. Diagn Cytopathol. 2000;22:52-59.
3. Lee KR, Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM, Inhorn SL. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol. 1997;90:278-284.
4. Carpenter AB, Davey DD. ThinPrep Pap test: performance and biopsy follow-up in a university hospital. Cancer. 1999;87:105-112.
5. Bolick DR, Hellman DJ. Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system. Acta Cytol. 1998;42:209-213.
6. Gupta PK, Baloch ZW, Cobbs C, Bibbo M. Processing liquid-based gynecologic specimens: comparison of the available techniques. Acta Cytol. 2001;45:995-998.
7. Michael CW, Hunter B. Interpretation of fine-needle aspirates processed by the ThinPrep technique: cytologic artifacts and diagnostic pitfalls. Diagn Cytopathol. 2000;23:6-13.
8. Nuovo GJ. Detection of human papillomavirus in Papanicolaou smears: correlation with pathologic findings and clinical outcome. Diagn Mol Pathol. 1998;7:158-163.
9. Malik SN, Wilkinson EJ, Drew PA, Bennett BB, Hardt NS. Do qualifiers of ASCUS distinguish between low- and high-risk patients? Acta Cytol. 1999;43:376-380.
10. Genest DR, Dean B, Lee KR, Sheets E, Crum CP, Cibas ES. Qualifying the cytologic diagnosis of "atypical squamous cells of undetermined significance" affects the predictive value of a squamous intraepithelial lesion on subsequent biopsy. Arch Pathol Lab Med. 1998;122:338-341.
11. Obwegeser JH, Brack S. Does liquid-based technology really improve detection of cervical neoplasia? A prospective, randomized trial comparing the ThinPrep Pap test with the conventional Pap test, including follow-up of HSIL cases. Acta Cytol. 2001;45:709-714.
12. Eltabbakh GH, Lipman JN, Mount SL, Morgan A. Significance of atypical squamous cells of undetermined significance on ThinPrep Papanicolaou smears. Gynecol Oncol. 2000;79:44-49.
13. Anton RC, Ramzy I, Schwartz MR, Younes P, Chakraborty S, Mody DR. Should the cytologic diagnosis of "atypical squamous cells of undetermined significance" be qualified? An assessment including comparison between conventional and liquid-based technologies. Cancer. 2001;93:93-99.
14. Menezes GA, Wakely PE Jr., Stripe DM, Nuovo GJ. Increased incidence of atypical Papanicolaou tests from ThinPreps of postmenopausal women receiving hormone replacement therapy. Cancer Cytopathol. 2001;93:357-363.
15. Nuovo GJ. Papanicolaou smears of squamous atypia. In: Nuovo GJ. Cytopathology of the lower female genital tract: an integrated approach. Baltimore: Williams and Wilkins, 1994:319-340.
16. Crum CP, Nuovo GJ. Genital papillomaviruses and related neoplasms. New York: Raven Press, 1991.
17. Menezes G, Euscher E, Schwartz B, Catania F, Chancellor J, Nuovo GJ. Utility of the in situ detection of HPV in Pap smears diagnosed as within normal limits. Acta Cytol. 2001;45:919-926.
18. Kjellberg L, Hallmans G, Ahren AM, et al. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer. 2000;82:1332-1338.
19. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85:958-964.
20. Brisson J, Morin C, Fortier M, et al. Risk factors for cervical intraepithelial neoplasia: differences between low- and high-grade lesions. Am J Epidemiol. 1994;140:700-710.
21. Deacon JM, Evans CD, Yule R, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer. 2000;83:1565-1572.
22. Yamazaki H, Sasagawa T, Basha W, Segawa T, Inoue M. Hybrid capture-II and LCR-E7 PCR assays for HPV typing in cervical cytologic samples. Int J Cancer. 2001;94:222-227.
23. Brennan MM, Lambkin HA, Sheehan CD, Ryan DD, O'Connor TC, Kealy WF. Detection of high-risk subtypes of human papillomavirus in cervical swabs: routine use of the Digene hybrid capture assay and polymerase chain reaction analysis. Br J Biomed Sci. 2001;58:24-29.
24. Clavel C, Masure M, Putaud I, et al. Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol. 1998;51:737-740.
25. Clavel C, Masure M, Bory JP, et al. Hybrid capture II-based human papillomavirus detection, a sensitive test to detect routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer. 1999;80:1306-1113.
26. Karlsen F, Kalantari M, Jenkins A, et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol. 1996;34:2095-2100.
27. Riethmuller D, Gay C, Bertrand X, et al. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction. Diagn Mol Pathol. 1999;8:157-164.
28. Nuovo GJ, Walsh LL, Gentile JL, Blanco JS, Koulos J. Correlation of the Papanicolaou smear and human papillomavirus type in women with biopsy-proven cervical squamous intraepithelial lesions. Am J Clin Pathol. 1991;96:544-548.
29. Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol. 2001;82:516-522.
30. Volk EE, Jax JM, Kuntzman TJ. Cytologic findings in cervical smears in patients using intramuscular medroxyprogesterone acetate (Depo-Provera) for contraception. Diagn Cytopathol. 2000;23:161-164.